Relief For Blepharitis & “Puralid Lipogel” Launched By Santen
Santen Pharmaceutical is one of the world’s leading specialist ophthalmic pharmaceutical companies, founded in Japan over a century ago and now serving patients all over the world.
A recent survey commissioned by Santen of blepharitis patients across three European countries revealed that current treatments are not providing full relief for some of the most severe and frequent symptoms experienced – including dry eyes and red, itchy and irritated eyelids.
PURALID LIPOGEL offers ophthalmologists a new option that works hard to cleanse and calm irritated eyelids, providing relief in the form of a gentle gel.
Blepharitis is a chronic and lifelong condition characterised by a cycle of exacerbations and remissions for the majority of patients.
It causes painful, red, swollen, greasy, itchy eyelids with a gritty ‘foreign object sensation’ and crusting of the eyelid margin.
Despite these recognisable symptoms, familiarity with the term ‘blepharitis’ differs across Europe, with almost half (42%) of patients surveyed admitting they had never heard of blepharitis before their diagnosis.
However, for ophthalmologists blepharitis is common across clinical practices. If untreated it can lead to troubling problems such as dry eyes, cysts and conjunctivitis. A recognised initial step in treating patients with blepharitis is to recommend eyelid cleansing.
“Blepharitis is a common and symptomatic disease and it has no established cure. It’s therefore crucial that we recognise that this condition needs a careful diagnostic approach and personalised management, and that we continue to educate patients on the value of lid hygiene, such as using warm compresses and cleansing the eyelids daily,” said Professor Edoardo Villani, University of Milan, Italy.
“However, we know that some patients struggle with current hygiene options and that even mild forms of blepharitis will only be successfully managed if patients persevere.”
Our survey surprisingly revealed that only 17% of people were fully satisfied with their blepharitis treatment. The application was either inconvenient or irritating to the eyes, among other reasons.
PURALID LIPOGEL is an easy-to-apply gel for the relief of acute flares (aggravated symptoms) and long-term maintenance (asymptomatic symptoms) of blepharitis.
It contains liposomes, which are known for their soothing, relieving and emollient properties, as well as their ability to facilitate the bioavailability of substances.
Other ingredients include tea tree oil, vitamin A, xanthan gum, ferulic acid, vitamin E TPGS and alfa bisabolol.
“Blepharitis can be sore, troublesome, uncomfortable and irritating for people so it can have a serious negative impact on quality of life. Our survey demonstrated that blepharitis interferes with daily activities and can prevent reading and normal use of a computer or phone,” said Luis Iglesias, President and Head of Santen EMEA.
“With blepharitis impacting how people can use screens plus digital device usage increasing since the COVID-19 pandemic, we hope to reaffirm our commitment to eye care with the launch of PURALID LIPOGEL.”
PURALID LIPOGEL has been launched to date in Austria, Bulgaria, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Portugal, Spain, Sweden and Switzerland, with further launches expected across Europe in the coming months.